Literature DB >> 32619024

The Effect of Anticoagulant Choice on Venous Thromboembolism Recurrence and Bleeding in Sickle Cell Disease.

Vishal K Gupta1, Rachel Strykowski1, Brittany Scarpato1, Romy Lawrence1, Sarah L Khan1, Jay Patel1, S Mehdi Nouraie2, Robyn T Cohen3, J Mark Sloan1,4, Elizabeth S Klings1,5.   

Abstract

Entities:  

Year:  2020        PMID: 32619024     DOI: 10.1002/ajh.25923

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  1 in total

1.  Use of rivaroxaban in sickle cell disease and venous thromboembolism: A case report.

Authors:  Waail Rozi; Elrazi Awadelkarim Hamid Ali; Abdulrahman F Al-Mashdali; Mohamed Abdelrazek; Mohamed A Yassin
Journal:  Medicine (Baltimore)       Date:  2021-12-23       Impact factor: 1.817

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.